Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial
Objective: To study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and secondary measures as other sleep variables,…Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease
Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…Dynamic dopamine transporter images are helpful for diagnosing parkinsonism
Objective: This study is aimed at introducing a new method to get Dopamine transporter (DAT) imaging simultaneously with regional cerebral flow (CBF) imaging. Background: DAT…Response inhibition in Parkinson’s disease
Objective: To study the brain networks underlying Response Inhibition in Parkinson's disease (PD). Background: While some PD patients can have significant executive dysfunction, others remain…Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease
Objective: Our primary aim was to study the effect of beta - blockers on the dynamics of extrapyramidal disorders in patients suffering from coronary heart…Efficacy and safety of a L-dopa delivery and monitoring medical device
Objective: The objective of this study is to evaluate algorithms in a medical device for l-dopa delivery and monitoring. This wearable medical device will measure…Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia
Objective: To test usefulness of arterial spin labeling (ASL) perfusion MRI for diagnoses of Parkinson's disease (PD) with dementia. Background: Dopamine transporter (DAT) images may…The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease
Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…
- « Previous Page
- 1
- …
- 22
- 23
- 24